AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.

AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.

Xehetasun bibliografikoak
Egile Nagusiak: Ana Isabel Rodríguez Pérez, María A Pedrosa, Carmen M Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, José Luis Labandeira-García
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2023-10-01
Saila:IBRO Neuroscience Reports
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2667242123010126

Internet

http://www.sciencedirect.com/science/article/pii/S2667242123010126

Antzeko izenburuak